Rebalix
Logo iSharesiShares · sheet of 5 September 2026
ETF sheet · official issuer and register data

iShares Emerging Markets Equity Enhanced Active UCITS ETF

EMME · IE000PHR51Q6 · USD · domicile Ireland
Equity · Global · Large & mid capactiveSFDR art. 8
Comparison benchmark: MSCI Emerging Markets Index (Net)
TER
0.30%+ trans. 0.49%
Fund size
145 m EUR
Tracking difference
not computable
🇮🇹 tax rate
25.40%white list 4.43%
Replication
Gestione attiva (dal KID)active management
Income
Distributingquarterly
Launch 29 Oct 2025 · costs from the KID as of 2 Sept 2026 · 485 securities held

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The Fund is actively managed and aims to achieve long-term capital growth on your investment. The Fund seeks to gain at least 70% of its investment exposure to equity securities (e.g. shares) of companies domiciled in, listed in, or the main business of which is in, emerging markets. The Fund will invest in equity securities, other equity-related securities and, when determined appropriate fixed income (FI) securities (such as bonds), money market instruments (MMIs) (i.e. debt securities with short-term maturities), deposits and cash. The FI securities…

Performance since series start (in euro) — base 100

29 Oct 202531 Aug 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
202613595126
High 135 (22 Jun 2026) · low 95 (16 Dec 2025) · last 126. Past performance is not indicative of future results.

Returns in euro

1 yearseries too young
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start+26.3%

Risk · 1 / 3 / 5 years

Volatility (ann.)
Max drawdown
Sharpe
Sortino
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · EMME · IE000PHR51Q61
RebalixEMME · IE000PHR51Q6 · sheet of 5 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years
Not honestly computable: active management: deviation from the index is management, not replication

Distributions · per share, in USD

Frequency: quarterly · last 12 months: 0.08 USD (1.29% of NAV) · 8 months of history: not a full year · last ex-date 16 Jul 2026
YearPaymentsTotal (USD)
202630.08

Holdings

Portfolio as declared by the issuer · 31 Aug 2026 · 485 securities · top-10 weight = 34.1%
Top holdingsWeight
TAIWAN SEMICONDUCTOR MANUFACTURING9.4%
SAMSUNG ELECTRONICS LTD8.0%
SK HYNIX5.7%
TENCENT HOLDINGS3.2%
ALIBABA GROUP HOLDING2.0%
MEDIATEK1.7%
HON HAI PRECISION INDUSTRY1.1%
CHINA CONSTRUCTION BANK CORP H1.1%
PETROLEO BRASILEIRO PREF SA1.0%
PING AN INSURANCE (GROUP) CO OF CH1.0%
Countries (% of fund)
Taiwan27.5%Korea (South)20.9%China19.3%Ireland9.0%Brazil4.2%
Sectors (% of fund)
Information Technology41.1%Financials17.4%Cash and/or Derivatives9.9%Consumer Discretionary6.6%Industrials5.6%

Listing venues

ESMA register (FIRDS) and official exchange lists
No EU listing in the ESMA register.

Official documents

Clickable links in the PDF
KID · www.blackrock.com/it/investitori-privati/literature/kiid/eu-priips-ish
Factsheet · www.ishares.com/gls-download/literature/fact-sheet/emme-ishares-emergi
Prospectus · www.blackrock.com/it/investitori-privati/literature/prospectus/ishares
The live sheet, always up to date
rebalix.com/en/etf/IE000PHR51Q6
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · EMME · IE000PHR51Q62